XENT
Intersect ENT, Inc
XENT
XENT
Delisted
XENT was delisted on the 12th of May, 2022.
109 hedge funds and large institutions have $373M invested in Intersect ENT, Inc in 2020 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 45 increasing their positions, 33 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
29% less call options, than puts
Call options by funds: $2.05M | Put options by funds: $2.89M
46% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 28
Holders
109
Holding in Top 10
2
Calls
$2.05M
Puts
$2.89M
Top Buyers
| 1 | +$5.63M | |
| 2 | +$4.64M | |
| 3 | +$3.78M | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$3.57M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$3.5M |
Top Sellers
| 1 | -$12.9M | |
| 2 | -$5.41M | |
| 3 | -$3.61M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.56M |
| 5 |
Jennison Associates
New York
|
-$3.47M |